Agilent Technologies (NYSE:A) Updates Q1 2025 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its first quarter 2025 earnings guidance on Monday morning. The company provided EPS guidance of 1.250-1.280 for the period, compared to the consensus EPS estimate of 1.370. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion. Agilent Technologies also updated its FY 2025 guidance to 5.540-5.610 EPS.

Agilent Technologies Trading Up 2.8 %

Agilent Technologies stock opened at $138.11 on Thursday. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. Agilent Technologies has a 12 month low of $124.10 and a 12 month high of $155.35. The stock’s 50 day simple moving average is $137.72 and its two-hundred day simple moving average is $137.43. The firm has a market cap of $39.68 billion, a PE ratio of 28.65, a P/E/G ratio of 5.91 and a beta of 1.07.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be given a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.72%. The ex-dividend date is Tuesday, December 31st. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio is currently 20.54%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on A. StockNews.com lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Tuesday. Bank of America raised their target price on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Citigroup raised their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Wells Fargo & Company started coverage on Agilent Technologies in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 target price for the company. Finally, Barclays decreased their price objective on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating for the company in a research note on Wednesday. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $143.40.

Insiders Place Their Bets

In other news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.